Analysis of JC virus DNA replication using a quantitative and high-throughput assay

Area of Science:

• Virology
• Molecular Biology
• Neuroscience

Background:

• Progressive Multifocal Leukoencephalopathy (PML) is a severe neurological disease caused by JC virus (JCV) lytic replication in the central nervous system.
• JC virus (JCV) encodes a large T-antigen (T-ag) helicase essential for viral DNA replication, similar to other polyomaviruses.

Purpose of the Study:

• To develop a quantitative, high-throughput assay for measuring JCV DNA replication.
• To investigate the roles of T-ag domains and viral origin sequences in JCV replication.
• To evaluate the assay's utility in identifying antiviral compounds targeting JCV.

Main Methods:

• Development of a luciferase-based assay using C33A cells, which efficiently accumulate nuclear T-ag for robust JCV replication.
• Utilizing the assay to examine the impact of T-ag domains and origin sequences on viral DNA replication.
• Testing the assay's capacity for antiviral drug screening.

Main Results:

• The developed assay provides a quantitative and high-throughput method for studying JCV DNA replication.
• Studies revealed specific requirements for T-ag domains and origin sequences.
• A significant stimulatory role for the transcription factor NF1 in JCV DNA replication was identified.
• The assay demonstrated effectiveness in inhibitor testing for potential antiviral drug discovery.

Conclusions:

• A novel, robust assay for JCV DNA replication has been established, facilitating further research into PML pathogenesis.
• The findings elucidate critical factors influencing JCV replication, including T-ag domains, origin sequences, and NF1.
• This assay serves as a valuable platform for the discovery of novel antiviral therapeutics against JCV infections.